Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple Sclerosis
出版年份 2020 全文链接
标题
Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple Sclerosis
作者
关键词
-
出版物
PHARMACOECONOMICS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-04
DOI
10.1007/s40273-020-00917-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development of an adaptive survey on the health economics’ perspective on Multiple Sclerosis (Preprint)
- (2020) Nils-Henning Ness et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Clinical outcome measures in multiple sclerosis: A review
- (2020) Hernan Inojosa et al. AUTOIMMUNITY REVIEWS
- Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
- (2019) Benjamin Turner et al. JOURNAL OF NEUROLOGY
- Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis
- (2019) Huihui Li et al. JOURNAL OF NEUROLOGY
- Early switch to fingolimod reduces rates of severe relapses over the long term: Post hoc analysis from the FREEDOMS, FREEDOMS II, and TRANSFORMS studies
- (2019) Judith Haas et al. Multiple Sclerosis and Related Disorders
- Review: Patient-reported outcomes in multiple sclerosis care
- (2019) Emanuele D'Amico et al. Multiple Sclerosis and Related Disorders
- Differentiating societal costs of disability worsening in multiple sclerosis
- (2019) Nils-Henning Ness et al. JOURNAL OF NEUROLOGY
- Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy
- (2018) Anat Achiron et al. Multiple Sclerosis Journal
- New insights into the burden and costs of multiple sclerosis in Europe: Results for Germany
- (2017) Peter Flachenecker et al. Multiple Sclerosis Journal
- Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study
- (2017) Ludwig Kappos et al. Multiple Sclerosis Journal
- New insights into the burden and costs of multiple sclerosis in Europe
- (2017) Gisela Kobelt et al. Multiple Sclerosis Journal
- New insights into the burden and costs of multiple sclerosis in Europe: Results for Germany
- (2017) Peter Flachenecker et al. Multiple Sclerosis Journal
- Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study
- (2017) Ludwig Kappos et al. Multiple Sclerosis Journal
- New insights into the burden and costs of multiple sclerosis in Europe
- (2017) Gisela Kobelt et al. Multiple Sclerosis Journal
- Determinants of high cost in multiple sclerosis patients: a claims and chart review study
- (2016) Xuehua Ke et al. CURRENT MEDICAL RESEARCH AND OPINION
- Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials
- (2016) Tobias Derfuss et al. Multiple Sclerosis and Related Disorders
- Brain health: time matters in multiple sclerosis
- (2016) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- Cost of Illness of Multiple Sclerosis - A Systematic Review
- (2016) Olivia Ernstsson et al. PLoS One
- The PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
- (2015) Tjalf Ziemssen et al. BMC Neurology
- Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review
- (2015) Tomas Kalincik NEUROEPIDEMIOLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Economic costs associated with an MS relapse
- (2014) K. O׳Connell et al. Multiple Sclerosis and Related Disorders
- Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity
- (2013) Karina Raimundo et al. BMC HEALTH SERVICES RESEARCH
- Direct and indirect cost burden associated with multiple sclerosis relapses: Excess costs of persons with MS and their spouse caregivers
- (2013) Hélène Parisé et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Treatment of Multiple Sclerosis Exacerbations
- (2011) Pavle Repovic et al. NEUROLOGIC CLINICS
- Economic Burden of Multiple Sclerosis
- (2010) Huseyin Naci et al. PHARMACOECONOMICS
- Multiple sclerosis relapses: a multivariable analysis of residual disability determinants
- (2008) M. Vercellino et al. ACTA NEUROLOGICA SCANDINAVICA
- An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare
- (2008) Marc A Koopmanschap et al. PHARMACOECONOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started